Literature DB >> 19413611

Pathological validation of supracricoid partial laryngectomy in laryngeal cancer.

D-I Sun1, K-J Cho, J-H Cho, Y-H Joo, C-K Jung, M-S Kim.   

Abstract

OBJECTIVES: To validate pathologically whether supracricoid partial laryngectomy is an oncologically sound procedure in cases with invasion of the thyroid cartilage, paraglottic space, pre-epiglottic space, anterior commissure, or subglottis.
DESIGN: A retrospective review of case notes was performed.
SETTING: Patients treated at a single institute in the Republic of Korea. PARTICIPANTS: Sixty-three patients who underwent supracricoid partial laryngectomy for laryngeal squamous cell carcinoma between June 1994 and May 2005 who were followed for at least 2 years. MAIN OUTCOME MEASURES: Local control and overall survival rates. Pathological invasion of the thyroid cartilage, anterior commissure, pre-epiglottic space, paraglottic space, or subglottis was also investigated as a cause of recurrence. Prognostic factors for local control and survival were evaluated with univariate and multivariate models.
RESULTS: Invasion of the anterior commissure, paraglottic space, thyroid cartilage, pre-epiglottic space, or subglottis had no significant impact on the recurrence or overall survival rates. The presence of a positive resection margin was significantly associated with recurrence in the univariate and multivariate analyses (P = 0.026, 0.028, respectively). When considering the prognostic factors influencing survival, the univariate analysis showed that N stage, a positive resection margin and recurrence had significant influences on the overall survival rate (P = 0.010, 0.0004 and 0.000 respectively). In the multivariate analysis, only recurrence affected the survival rate (P = 0.002).
CONCLUSION: Supracricoid partial laryngectomy can be used with oncological safety in selected cases of laryngeal cancer with invasion of the anterior commissure, thyroid cartilage, pre-epiglottic space, paraglottic space, or subglottis.

Entities:  

Mesh:

Year:  2009        PMID: 19413611     DOI: 10.1111/j.1749-4486.2008.01854.x

Source DB:  PubMed          Journal:  Clin Otolaryngol        ISSN: 1749-4478            Impact factor:   2.597


  6 in total

1.  Guidelines for the Surgical Management of Laryngeal Cancer: Korean Society of Thyroid-Head and Neck Surgery.

Authors:  Soon-Hyun Ahn; Hyun Jun Hong; Soon Young Kwon; Kee Hwan Kwon; Jong-Lyel Roh; Junsun Ryu; Jun Hee Park; Seung-Kuk Baek; Guk Haeng Lee; Sei Young Lee; Jin Choon Lee; Man Ki Chung; Young Hoon Joo; Yong Bae Ji; Jeong Hun Hah; Minsu Kwon; Young Min Park; Chang Myeon Song; Sung-Chan Shin; Chang Hwan Ryu; Doh Young Lee; Young Chan Lee; Jae Won Chang; Ha Min Jeong; Jae-Keun Cho; Wonjae Cha; Byung Joon Chun; Ik Joon Choi; Hyo Geun Choi; Kang Dae Lee
Journal:  Clin Exp Otorhinolaryngol       Date:  2017-01-03       Impact factor: 3.372

2.  Transoral resection of laryngeal and hypopharyngeal cancers.

Authors:  Sultan Pradhan; Marzi Mehta; Arsheed Hakeem; Jagadish Tubachi; R Kannan
Journal:  Indian J Surg Oncol       Date:  2010-11-21

Review 3.  Evidence and evidence gaps of laryngeal cancer surgery.

Authors:  Susanne Wiegand
Journal:  GMS Curr Top Otorhinolaryngol Head Neck Surg       Date:  2016-12-15

4.  Modified supracricoid laryngectomy: oncological and functional outcomes in the elderly.

Authors:  Eugenia Allegra; Teresa Franco; Serena Trapasso; Rossana Domanico; Alessandro La Boria; Aldo Garozzo
Journal:  Clin Interv Aging       Date:  2012-11-08       Impact factor: 4.458

5.  Relationship between preepiglottic space invasion and lymphatic metastasis in supracricoid partial laryngectomy with cricohyoidopexy.

Authors:  Young-Hoon Joo; Jun-Ook Park; Kwang-Jae Cho; Min-Sik Kim
Journal:  Clin Exp Otorhinolaryngol       Date:  2014-08-01       Impact factor: 3.372

6.  Prognostic role of resection margin in open oncologic laryngeal surgery: survival analysis of a cohort of 139 patients affected by squamous cell carcinoma.

Authors:  Carmelo Saraniti; Riccardo Speciale; Salvatore Gallina; Pietro Salvago
Journal:  Braz J Otorhinolaryngol       Date:  2018-06-02
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.